in shr , prevention of the development of hypertension was noted after 1.5 weeks of chronic oral administration of labetalol 25 , 50 and 100 mg/kg/day , while bradycardia occurred beginning with the day of administration .
C0022860
labetalol
C0428977
bradycardia